Trial Profile
Retrospective study comparing the safety and treatment outcome of EGb 761 to donepezil in patient with Alzheimer's dementia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2018
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; EGb 761 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- 16 Jan 2018 New trial record
- 10 Jan 2018 Results published in the International Journal of Clinical Pharmacology and Therapeutics